Additive expulsion effect of tamsulosin after shock wave lithotripsy for upper ureteral stones

Korean Journal of Urology

Volumn 47, Issue 8, 2006, Pages 813-817

  Han, Min Cheol ^a   Jeong, Woo Sik ^a   Shim, Bong Suk ^a  

^a Ewha Womans University School of Medicine   (South Korea)

Author keywords

Extracorporeal shockwave lithotripsy; Tamsulosin; Urinary calculi

Indexed keywords

ANALGESIC AGENT; CAROVERINE; KETOROLAC TROMETAMOL; SPAMON; SPASMOLYTIC AGENT; TAMSULOSIN;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG USE; EXTRACORPOREAL LITHOTRIPSY; FEMALE; GENDER; HUMAN; INJECTION; MALE; PAIN; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT; URETER STONE;

EID: 33750999593     PISSN: 04944747     EISSN: None     Source Type: Journal    
DOI: 10.4111/kju.2006.47.8.813     Document Type: Article

References (27)

1. Peschel R, Janetschek G, Bartsch G. Extracorporeal shock wave lithotripsy versus ureteroscopy for distal ureteral calculi: a prospective randomized study. J Urol 1999;162:1909-12
2. Lingeman JE. Extracorporeal shock wave lithotripsy. Development, instrumentation, and current status. Urol Clin North Am 1997;24:185-211
3. Ehreth JT, Drach GW, Arnett ML, Barnett RB, Govan D, Lingeman J, et al. Extracorporeal shock wave lithotripsy: multicenter study of kidney and upper ureter versus middle and lower ureter treatments. J Urol 1994;152:1379-85
4. Cervenakov I, Fillo J, Mardiak J, Kopecny M, Smirala J, Lepies P. Speedy elimination of ureterolithiasis in lower part of ureters with the alpha1-blocker tamsulosin. Int Urol Nephrol 2002;34:25-9
5. Danuser H, Weiss R, Abel D, Walter B, Scholtysik G, Mettler D, et al. Systemic and topical drug administration in the pig ureter: effect of phosphodiesterase inhibitors alpha1, beta and beta2-adrenergic receptor agonists and antagonists on the frequency and amplitude of ureteral contractions. J Urol 2001; 166:714-20
6. Peters HJ, Parekh N, Popa G. Effect of adrenergic and cholinergic agents on ureteral functions in dogs. Urol Int 1979; 34:137-46
7. 1-Adrenoceptor subtypes: a synopsis of their pharmacology and molecular biology. Drug Dev Res 1996;39: 54-107
8. 1-adrenoceptor subtypes. Eur J Pharmacol 1999;375:261-76
9. Gravina GL, Costa AM, Ronchi P, Galatioto GP, Angelucci A, Castellani D, et al. Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones. Urology 2005;66:24-8
10. Chaussy C, Schmiedt E, Jocham D, Brendel W, Forssmann B, Walther V. First clinical experience with extracorporeally induced destruction of kidney stone by shock waves. J Urol 1982;127:417-20
11. Segura JW, Preminger GM, Assimos DG, Dretler SP, Kahn RI, Lingeman JE, et al. Ureteral stones clinical guidelines panel summary report on the management of ureteral calculi. The American Urological Association. J Urol 1997;158:1915-21
12. Kang SC, Ryu JK, Yoon SM. Clinical outcome of Therasonic LTS and SDS-5000 for the treatment of urinary stones. Korean J Urol 2005;46:275-80
13. Matin SF, Yost A, Streem SB. Extracorporeal shock-wave lithotripsy: a comparative study of electrohydraulic and electromagnetic units. J Urol 2001;166:2053-6
14. Kim HS, Kim YG. Clinical experience of extracorporeal shock wave lithotripsy (ESWL) using Dornier MPL 9200X lithotriptor. Korean J Urol 2003;44:430-5
15. Lee GB, Rho J, Jang DS. Clinical experience of extracorporeal shock wave lithotripsy with the Dornier Compact Delta. Korean J Urol 2003;44:139-44
16. Ng CF, McLornan L, Thompson TJ, Tolley DA. Comparison of 2 generations of piezoelectric lithotriptors using matched pair analysis. J Urol 2004;172:1887-91
17. Oh BS, Hwang EC, Chae MJ, Oh KJ, Kang TW, Kwon DD, et al. Efficacy of the 3rd generation extracorporeal shock wave lithotriptor (Piezolith 3000®) for treating patients with urinary tract calculi. Korean J Urol 2005;46:1278-83
18. Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureteral stones. Urology 2000;56:579-82
19. Cooper JT, Stack GM, Cooper TP. Intensive medical management of ureteral calculi. Urology 2000;56:575-8
20. Morita T, Wada I, Saeki H, Tsuchida S, Weiss RM. Ureteral urine transport: changes in bolus volume, peristaltic frequency, intraluminal pressure and volume of flow resulting from autonomic drugs. J Urol 1987;137:132-5
21. Morita T, Ando M, Kihara K, Oshima H. Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol Urodyn 1994;13:315-21
22. Obara K, Takeda M, Shimura H, Kanai T, Tsutsui T, Komeyama T, et al. Alpha-1 adrenoreceptor subtypes in the human ureter: characterization by RT-PCR and in situ hybridization. J Urol 1996;155(Suppl):472A, abstract 646
23. Dellabella M, Milanese G, Muzzonigro G. Efficacy of tamsulosin in the medical management of juxtavesical ureteral stones. J Urol 2003;170:2202-5
24. Resim S, Ekerbicer H, Ciftci A. Effect of tamsulosin on the number and intensity of ureteral colic in patients with lower ureteral calculus. Int J Urol 2005;12:615-20
25. Kupeli B, Irkilata L, Gurocak S, Tunc L, Kirac M, Karaoglan U, et al. Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urology 2004;64:1111-5
26. Ahn DW, Oh MM. Experience of extracorporeal shock wave lithotripsy (ESWL) with EDAP-LT01: a report of 660 cases. Korean J Urol 2001;42:483-8
27. O'Leary MP. Tamsulosin: current clinical experience. Urology 2001;58(Suppl 6A):42-8